US boosts H1N1 vaccine supply with $884 million buy
This article was originally published in Scrip
Executive Summary
The US health and human services (HHS) department is spending another $884 million to buy novel influenza A (H1N1) vaccine antigen and adjuvant, bringing its total H1N1 vaccine ingredient purchases to more than $1.82 billion in the past two months.